Výsledky vyhledávání - "X. E. Larco Rojas"

AB0451 FACTORS ASSOCIATED WITH ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Autor: C. Sieiro Santos, C. Moriano, I. González Fernández, X. E. Larco Rojas, C. Álvarez Castro, E. Diez Alvarez

Publikováno v: Annals of the Rheumatic Diseases. 81:1353.3-1353

BackgroundPregnancies in systemic lupus erythematosus (SLE) are considered high risk and associated with maternal and obstetric complications.ObjectivesOur goal with this study was to determine the most important predictors for each of the main adver

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2640f6820695e8696b94a319f6321b0
https://doi.org/10.1136/annrheumdis-2022-eular.303

Zobrazit plný text záznamu

AB0328 CLINICAL AND SEROLOGICAL DIFFERENCES BETWEEN PRIMARY SJOGREN’S SYNDROME PHENOTYPES

Autor: Clara Moriano, T. Pérez Sandoval, E. Diez Alvarez, A. López Robles, X. E. Larco Rojas

Publikováno v: Annals of the Rheumatic Diseases. 80:1189.1-1189

Background:Primary Sjogren’s Syndrome (PSS) is an autoimmune and lymphoproliferative disease with a heterogeneous presentation. It has been postulated that there may be different phenotypes, in some cases presenting a more aggressive disease with s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47018bd840e3aef1c21e50d2fbdc4b76
https://doi.org/10.1136/annrheumdis-2021-eular.2959

Zobrazit plný text záznamu

POS0752 INTERSTITIAL LUNG INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: RELEVANT CLINICAL CHARACTERISTICS. OUR EXPERIENCE IN A THIRD LEVEL HOSPITAL

Autor: A. López Robles, M. T. Perez Sandoval, E. Diez Alvarez, Clara Moriano, X. E. Larco Rojas, I. González Fernández, M. E. Vallejo Pascual

Publikováno v: Annals of the Rheumatic Diseases. 80:628.2-629

Background:Lung involvement1 in Systemic Lupus Erythematosus (SLE) is heterogeneous, with the pleura being more frequently affected. Associated diffuse interstitial lung disease (ILD) is rare (3-13%) with difficult diagnosis and therapeutic managemen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2c0135c52a3eaeb1c9feb12989a25dbb
https://doi.org/10.1136/annrheumdis-2021-eular.2726

Zobrazit plný text záznamu

AB0568 CORRELATION BETWEEN SKIN AND JOINT INVOLVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EXPERIENCE FROM A THIRD LEVEL HOSPITAL

Autor: Clara Moriano, C. Álvarez Castro, C. Sieiro Santos, E. Diez Alvarez, T. Pérez Sandoval, X. E. Larco Rojas

Publikováno v: Annals of the Rheumatic Diseases. 80:1321.1-1321

Background:Determining the relationship between severity of skin and joint disease is essential for better phenotyping of patients and determine whether clinical features of arthritis can associate with psoriasis.Objectives:To characterize the relati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::039cbd923dec3378750f9991eece0246
https://doi.org/10.1136/annrheumdis-2021-eular.1226

Zobrazit plný text záznamu

SAT0180 ANTIMALARIAL DRUGS ASSOCIATED RETINOPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Autor: X. E. Larco Rojas, T. Pérez Sandoval, Clara Moriano, E. Diez Alvarez, A. López Robles, A. Crespo Golmar

Publikováno v: Annals of the Rheumatic Diseases. 79:1031.3-1031

Background:The antimalarials remain to be the main treatment for Systemic Lupus Erythematosus (SLE). Its most important limitation when you want to increase dose or remain using them is the occurrence of retinal toxicity, which appears in a small num

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4981d724c89f3d45cda58a41c2507bab
https://doi.org/10.1136/annrheumdis-2020-eular.5996

Zobrazit plný text záznamu

AB0768 TREATMENT WITH TOFACITINIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTER STUDY OF 87 PATIENTS IN CLINICAL PRACTICE

Publikováno v: Annals of the Rheumatic Diseases. 79:1682.1-1682

Background:Tofacitinib (TOFA) is the first JAKi approved for psoriatic arthritis (PsA) in Europe (July 2018). TOFA has shown efficacy in refractory patients to anti-TNF in Randomized Clinical Trials (RCT) (Gladman D. NEJM 2017; 377: 1525-36).Objectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::defcfa4bb6fd0531b4f48e667e67664d
https://doi.org/10.1136/annrheumdis-2020-eular.2903

Zobrazit plný text záznamu

AB0689 THE IMPORTANCE OF THE SUN. VITAMIN D AND SPONDYLOARTHRITIS: OUR EXPERIENCE IN A THIRD LEVEL HOSPITAL

Autor: C. Álvarez Castro, A. López Robles, I. González Fernández, X. E. Larco Rojas, Clara Moriano, M. E. Vallejo Pascual

Publikováno v: Annals of the Rheumatic Diseases. 79:1640.2-1640

Background:Vitamin D plays an important role in the pathogenesis of autoimmune diseases, so that it has been shown that an adequate level is associated with a lower risk of developing this group of entities as well as a lower severity of them. Specif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::979a058d35f61b0410f8c297f69ebae0
https://doi.org/10.1136/annrheumdis-2020-eular.4191

Zobrazit plný text záznamu

SAT0622-HPR SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN BIOLOGICAL TREATMENT OVER 65 YEARS OF AGE

Autor: A. López Robles, Clara Moriano, X. E. Larco Rojas, I. González Fernández, A. Crespo Golmar, T. Pérez Sandoval

Publikováno v: Annals of the Rheumatic Diseases. 79:1271.2-1271

Background:A bias has been described with the lowest prescription of biologic treatments (bDMARD) in patients with rheumatoid arthritis (RA) in the elderly, despite presenting activity rates comparable to young population and higher risk of functiona

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c2d3516fe43ee9a74f935490ed0beab
https://doi.org/10.1136/annrheumdis-2020-eular.5260

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání